SCHEMBL365770

SCHEMBL365770

CC(=O)c1cc(O)c2c(C(N)=O)c3ccccn3c2c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 10/20 0.45
BAZ2A Q9UIF9 10/20 0.45
BRD4 O60885 2/20 0.36
BRD9 Q9H8M2 2/20 0.36
BRD2 P25440 1/20 0.36
BRD3 Q15059 1/20 0.36
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
APAF1 O14727 1/20 0.34
ALDH1A1 P00352 1/20 0.34
G6PD P11413 1/20 0.34
PABPC1 P11940 1/20 0.34
CACNA1B Q00975 1/20 0.34
APBA1 Q02410 1/20 0.34
KMT2A Q03164 1/20 0.34
SAE1 Q9UBE0 1/20 0.34
UBA2 Q9UBT2 1/20 0.34
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL367221 0.91 BAZ2B (0.42) BAZ2BBAZ2ABRD4MAPTKDM4E
SCHEMBL365022 0.88 PTGS2 (0.39) BAZ2BBAZ2AMAPTKDM4EALDH1A1
SCHEMBL365788 0.88 BAZ2B (0.45) BAZ2BBAZ2ABRD4BRD9BRD2
SCHEMBL364537 0.86 BAZ2B (0.38) BAZ2BBAZ2AMAPTKDM4EMEN1
SCHEMBL365020 0.84 BAZ2B (0.43) BAZ2BBAZ2AMAPTKDM4EALDH1A1
SCHEMBL367255 0.83 PTGS2 (0.42) BAZ2BBAZ2AMAPT
SCHEMBL367329 0.78 BAZ2B (0.47) BAZ2BBAZ2ABRD4BRD9MAPT
SCHEMBL366820 0.78 IDO1 (0.43) BAZ2BBAZ2AMAPTKDM4EALDH1A1
SCHEMBL365406 0.77 STS (0.39) MAPTKDM4EMEN1APAF1ALDH1A1
SCHEMBL365255 0.76 RAB9A (0.37) BAZ2BBAZ2AMAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed